Abstract
Indoramin has been tested for its ability to inhibit the uptake of tritiated (–)-noradrenaline and 5-hydroxytryptamine into rat brain cortical slices. Other α-blocking agents and tricyclic antidepressants were included for comparison. Activity against noradrenaline uptake is probably not important in the therapeutic action of indoramin. However, inhibition of 5-hydroxytryptamine uptake may be responsible for the sedation in high dosage noted by some investigators